Worth reading
56In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
8000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status report for the 11th stock acquisition rights issued through a third-party allotment (with an exercise price adjustment clause)
Who receives how much
Shares delivered during the month: 8,000 new shares. Treasury shares transferred: 0 shares
EVO FUND (issued on 26 December 2025)
The lower thin line represents the existing number of shares to which these shares will be added.
Existing Shares and Increase
+0.00%Rate of increase
90,535,233 shares90,543,233Shares
Exercise ratio subject to exercise restrictions: 0.0% (8,000 shares delivered / 75,355,233 listed shares at the time payment for issuance was made)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price: ¥30 (28 September 2026). Details and floor of adjustment provisions are Not disclosed
Number of Stock Acquisition Rights
Total issued: 700,000 rights. Exercised during the month covered: 80 rights; unexercised at the end of the preceding month: 548,200 rights; unexercised at the end of the month covered: 548,120 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments
Most recent equity financing
26 December 2025: Issuance of the 11th Stock Acquisition Rights, with EVO FUND as the allottee (detailed amount: Not disclosed), 26 December 2025: Issuance of the 12th Series Stock Acquisition Rights (detailed amount: Not disclosed)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for the 11th stock acquisition rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 8,000 new shares. Treasury shares transferred: 0 shares |
| Intended allottee | EVO FUND (issued on 26 December 2025) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 0.0% (8,000 shares delivered / 75,355,233 listed shares at the time payment for issuance was made) |
| Total number of issued shares | 90,535,233 shares (as of the end of the month preceding the month covered, including 9,227 treasury shares) → 90,543,233 shares (calculated number of shares as of the end of the month covered) |
| Exercise price | Exercise price: ¥30 (28 September 2026). Details and floor of adjustment provisions are Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 700,000 rights. Exercised during the month covered: 80 rights; unexercised at the end of the preceding month: 548,200 rights; unexercised at the end of the month covered: 548,120 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments |
| Most recent equity financing | 26 December 2025: Issuance of the 11th Stock Acquisition Rights, with EVO FUND as the allottee (detailed amount: Not disclosed), 26 December 2025: Issuance of the 12th Series Stock Acquisition Rights (detailed amount: Not disclosed) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.